Stien De Coninck

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Magnetic Resonance

Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Stien De Coninck, Juliette Roels, Beatrice Lintermans, Sara T'Sas, Tom Taghon, David J Curtis, Tim Pieters, Steven Goossens, Pieter Van Vlierberghe
Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia. Blood advances (2024)
Stien De Coninck, Juliette Roels, Béatrice Lintermans, Sara T'Sas, Tom Taghon, David J Curtis, Tim Pieters, Steven Goossens, Pieter Van Vlierberghe
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia. Blood advances 8 (11) (2024)
Stien De Coninck, Juliette Roels, Béatrice Lintermans, Sara T'Sas, Tom Taghon, David J Curtis, Tim Pieters, Steven Goossens, Pieter Van Vlierberghe
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia. Blood advances 8 (11) (2024)